| Symbol | SMTI |
|---|---|
| Name | SANARA MEDTECH INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Industrial Specialties |
| Address | 1200 SUMMIT AVENUE,SUITE 414, FORT WORTH, Texas, 76102, United States |
| Telephone | +1 817 529-2300 |
| Fax | — |
| — | |
| Website | https://www.sanaramedtech.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000714256 |
| Description | Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. Additional info from NASDAQ: |
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
Read moreNew Form 425 - Sanara MedTech Inc. <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001493152-26-039469 <b>Size:</b> 25 KB
Read more(30% Negative) SANARA MEDTECH INC. (SMTI) Reports Q3 2026 Financial Results
Read moreSanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
Read moreNew Form 425 - Sanara MedTech Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001376339-26-000084 <b>Size:</b> 74 KB
Read moreNew Form 425 - Sanara MedTech Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001493152-26-037133 <b>Size:</b> 401 KB
Read moreNew Form 425 - Sanara MedTech Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001493152-26-037123 <b>Size:</b> 86 KB
Read moreNew Form 8-K/A - Sanara MedTech Inc. <b>Filed:</b> 2026-08-11 <b>AccNo:</b> 0001493152-26-037112 <b>Size:</b> 272 KB <br />Item 1.01: Entry into a Material Definitive Agreement <br />Item 7.01: Regulation FD Disclosure <br />Item 9.01: Financial Statements and Exhibits
Read moreSanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Read moreNew Form SCHEDULE 13G/A - Sanara MedTech Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001214659-26-009273 <b>Size:</b> 8 KB
Read more